Skip to content
Annalist
Companies Atlas Screener Compare Deal Lab For AI agents Data Quality Method

Novo Nordisk A/S

NVO · NYSE · Health care, pharmaceuticals · Denmark · IFRS · Fiscal year ends December

Latest report: FY2025, the fiscal year ended 31 December 2025, released 4 February 2026. Snapshot FY2025_e7e4de91.

Overview

Revenue, fiscal year
+6.4% year on year
Operating profit, fiscal year
−0.5% year on year
Net income, fiscal year
n/a
Diluted EPS, fiscal year
+1.8% year on year
Operating margin, fiscal year
−2.9pp year on year
Return on invested capital, fiscal year
−17.8pp year on year

Select a figure to see the document it came from.

Key Findings

Findings for the latest fiscal year, with their history over earlier years.

  1. Revenue for the fiscal year ended 31 December 2025 was DKK309.1 billion, 6.4% higher than in the previous fiscal year.

    Weakenedin FY2025 · stated since FY20236.4% from 25.0% in FY2024
    Rule: Revenue against the previous fiscal year · Sources 20-F 2025-12
    History of this finding, 3 records
    1. FY2025 WeakenedRevenue for the fiscal year ended 31 December 2025 was DKK309.1 billion, 6.4% higher than in the previous fiscal year.Recorded from FY2025_e7e4de91 · data update
    2. FY2024 WeakenedRevenue for the fiscal year ended 31 December 2024 was DKK290.4 billion, 25.0% higher than in the previous fiscal year.Reconstructed · data update
    3. FY2023 NewRevenue for the fiscal year ended 31 December 2023 was DKK232.3 billion, 31.3% higher than in the previous fiscal year.Reconstructed · initial
  2. The operating margin for fiscal 2025 was 41.3%, 2.9 percentage points lower than a year earlier.

    Newin FY2025 · first stated
    Rule: Operating margin against a year earlier · Sources 20-F 2025-12
    History of this finding, 5 records
    1. FY2025 NewThe operating margin for fiscal 2025 was 41.3%, 2.9 percentage points lower than a year earlier.Recorded from FY2025_e7e4de91 · data update
    2. FY2025 RetiredThe finding changed to lower than a year earlier.Recorded from FY2025_e7e4de91 · data update
    3. FY2024 NewThe operating margin for fiscal 2024 was 44.2%, unchanged from a year earlier.Reconstructed · data update
    4. FY2024 RetiredThe finding changed to unchanged from a year earlier.Reconstructed · data update
    5. FY2023 NewThe operating margin for fiscal 2023 was 44.2%, 1.9 percentage points higher than a year earlier.Reconstructed · initial
  3. Return on invested capital for fiscal 2025 was 34.2%, against 51.9% a year earlier.

    Strengthenedin FY2025 · stated since FY2024
    Rule: Return on invested capital against a year earlier · Sources 20-F 2025-12, 20-F 2024-12
    History of this finding, 4 records
    1. FY2025 StrengthenedReturn on invested capital for fiscal 2025 was 34.2%, against 51.9% a year earlier.Recorded from FY2025_e7e4de91 · data update
    2. FY2024 NewReturn on invested capital for fiscal 2024 was 51.9%, against 64.8% a year earlier.Reconstructed · data update
    3. FY2024 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    4. FY2023 NewReturn on invested capital for fiscal 2023 was 64.8%, against 55.9% a year earlier.Reconstructed · initial
  4. Free cash flow for fiscal 2025 was DKK59.0 billion.

    Interpretation. Operating cash flow paid for all capital expenditure, and the rest is free for dividends, share buybacks or debt repayment.

    Weakenedin FY2025 · stated since FY2023
    Rule: Free cash flow · Sources 20-F 2025-12
    History of this finding, 3 records
    1. FY2025 WeakenedFree cash flow for fiscal 2025 was DKK59.0 billion.Recorded from FY2025_e7e4de91 · data update
    2. FY2024 WeakenedFree cash flow for fiscal 2024 was DKK73.8 billion.Reconstructed · data update
    3. FY2023 NewFree cash flow for fiscal 2023 was DKK83.1 billion.Reconstructed · initial
  5. Net debt was DKK113.1 billion at 31 December 2025, 0.8 times EBITDA for fiscal 2025.

    Strengthenedin FY2025 · stated since FY2023
    Rule: Net debt or net cash · Sources 20-F 2025-12
    History of this finding, 3 records
    1. FY2025 StrengthenedNet debt was DKK113.1 billion at 31 December 2025, 0.8 times EBITDA for fiscal 2025.Recorded from FY2025_e7e4de91 · data update
    2. FY2024 StrengthenedNet debt was DKK93.9 billion at 31 December 2024, 0.7 times EBITDA for fiscal 2024.Reconstructed · data update
    3. FY2023 NewNet debt was DKK18.3 billion at 31 December 2023, 0.2 times EBITDA for fiscal 2023.Reconstructed · initial

Records before FY2025 are reconstructed from the latest snapshot. Ledger: findings.json.

Credit, liquidity, earnings quality and score findings: Analysis.

Data

Source documents5 documents, latest 20-F for the year to 31 December 2025List
SnapshotFY2025_e7e4de91

Corporate Events

Corporate events are listed for companies whose figures come from 10-K and 10-Q filings; none are listed for this company.

Earnings, Returns and Balance Sheet

Revenue

By fiscal year, Danish kroner

Operating Profit

By fiscal year, Danish kroner

Margins

By fiscal year, per cent

Returns

By fiscal year, per cent

Free Cash Flow

Operating cash flow less capital expenditure, by fiscal year, Danish kroner

Net Debt

Total debt less cash and short-term investments, at fiscal year end, Danish kroner

Diluted Earnings per Share

By fiscal year, as reported

Financial Statements

Figures as filed. Select a figure for its source document and method; a small d marks a figure derived from other figures of the same report.

The statements are loading. They are also available as JSON and CSV.

Ratios

Select a ratio for its formula and the figures it uses, each with its document; (i) gives its definition.

The ratios are loading.

Source Documents

Documents of this snapshot, latest first.

DocumentDateId
20-F for the year to 31 December 20254 Feb 202620-F:0000353278-26-000012
20-F for the year to 31 December 20245 Feb 202520-F:0001628280-25-003920
20-F for the year to 31 December 202331 Jan 202420-F:0001628280-24-002635
20-F for the year to 31 December 20221 Feb 202320-F:0001628280-23-001868
20-F for the year to 31 December 20212 Feb 202220-F:0001628280-22-001639

Checks

211210 of 211 checks passed, 1 warning
Annual reports read0 of 1 passedEvery annual report on Form 20-F used is that of the company and gives its fiscal year in the accounting basis of the company record. A report that cannot be read is not used. Checked at warning level.
A figure
Fiscal calendar11 passedFiscal years last 350 to 380 days, and each starts on the day after the one before. Checked at error level.
Coverage2 passedThe latest fiscal year gives total assets and a profit figure. Checked at error level.
Balance sheet identity6 passedTotal assets equal total liabilities and equity at each balance sheet date. Checked at error level.
Gross profit6 passedRevenue less cost of sales equals the gross profit that the company presents. A gross profit that differs is withheld, and so is a cost of sales that the company gives without gross profit. Checked at warning level.
Agreement between annual reports185 passedA value of a year that the annual report of the year and that of the next year give in the same amount. A value that the later report gives differently is listed as a restatement, and the later value is used. Checked at warning level.

Data Quality

How many values of this snapshot the checks prove, and how many Annalist derives, withholds and tracks as restated. Every company.

Values published264
Confirmed by other figures73.9%, 195 values
Confirmed by a second document70.1%, 185 values
Derived from reported figures0.0%, 0 values
Values withheld0
Restated figures tracked20
Changes compared on one basis1
Company lines mapped0 of 0 reviewed

Citation

Annalist, Novo Nordisk A/S, snapshot novo-nordisk/FY2025_e7e4de91 (as of FY2025); <item label>, <period>; source <document id> (<document url>)

Snapshot FY2025_e7e4de91 · dataset SHA-256 e7e4de911203c07ac59a779573353f8c277b6e1d8c4cbdd07aed6b8fa06cc162 · findings rules 0.5

Data: info.json · dataset.json · validation.json · documents.json